am 251 and jwh-133
am 251 has been researched along with jwh-133 in 14 studies
Research
Studies (14)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 9 (64.29) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Adinolfi, B; Benetti, V; Cascio, MG; Di Marzo, V; Ferrarini, PL; Ligresti, A; Lucchesi, V; Manera, C; Martinelli, A; Masini, E; Nieri, P; Saccomanni, G; Tuccinardi, T | 1 |
| Allen, JG; Babij, P; Fotsch, C | 1 |
| Brogi, S; Corelli, F; Di Marzo, V; Ligresti, A; Mugnaini, C; Pasquini, S; Tafi, A | 1 |
| Campillo, NE; de Ceballos, ML; Girón, R; González-Naranjo, P; Martín-Fontelles, MI; Martin-Requero, A; Páez, JA; Pérez, C; Pérez-Macias, N; Roca, C; Sánchez-Robles, E; Vaca, G | 1 |
| Choi, JI; Yoon, MH | 1 |
| Davison, JS; Ho, W; Mathison, R; Pittman, QJ; Sharkey, KA | 1 |
| Idris, AI; Landao-Bassonga, E; Ralston, SH; Sophocleous, A; van't Hof, RJ | 1 |
| Chai, SY; Chen, CJ; Li, YN; Li, YY; Lv, S; Ni, JB; Storr, M; Wu, RH; Yüce, B | 1 |
| Cui, N; Du, Y; Li, Q; Ma, H; Zhang, Y | 1 |
| Hinz, B; Peters, K; Ramer, R; Salamon, A; Schmuhl, E | 1 |
| Biala, G; Kruk-Slomka, M; Michalak, A | 1 |
| Biala, G; Boguszewska-Czubara, A; Budzynska, B; Kruk-Slomka, M; Slomka, T | 1 |
| Aguiar, DC; Bastos, JR; Coimbra, CC; Costa, RB; Hott, SC; Mansur, FS; Moreira, FA; Resstel, LB; Viana, TG | 1 |
| Bi, GH; Galaj, E; He, Y; Xi, ZX | 1 |
Reviews
1 review(s) available for am 251 and jwh-133
| Article | Year |
|---|---|
Emerging targets in osteoporosis disease modification.
Topics: Animals; Biomarkers; Bone Density; Bone Resorption; Humans; Osteoporosis | 2010 |
Other Studies
13 other study(ies) available for am 251 and jwh-133
| Article | Year |
|---|---|
Rational design, synthesis, and pharmacological properties of new 1,8-naphthyridin-2(1H)-on-3-carboxamide derivatives as highly selective cannabinoid-2 receptor agonists.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Humans; Jurkat Cells; Models, Molecular; Molecular Structure; Naphthyridines; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2009 |
Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2.
Topics: Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Quinolones; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Recombinant Proteins; Stereoisomerism | 2011 |
Indazolylketones as new multitarget cannabinoid drugs.
Topics: Aspartic Acid Endopeptidases; Butyrylcholinesterase; Cannabinoids; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Cholinesterase Inhibitors; Drug Design; Humans; Indazoles; Ketones; Neurons; Receptor, Cannabinoid, CB2 | 2019 |
Pharmacologic interaction between cannabinoid and either clonidine or neostigmine in the rat formalin test.
Topics: Adrenergic alpha-Agonists; Analgesics; Animals; Antineoplastic Agents; Behavior, Animal; Benzoxazines; Cannabinoids; Cholinesterase Inhibitors; Clonidine; Dose-Response Relationship, Drug; Drug Interactions; Formaldehyde; Indoles; Injections, Spinal; Male; Morpholines; Naphthalenes; Neostigmine; Pain Measurement; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug | 2003 |
Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats.
Topics: Animals; Cannabinoids; Gastrointestinal Transit; Lipopolysaccharides; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Time Factors | 2004 |
Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor.
Topics: Animals; Bone and Bones; Bone Density; Bone Marrow Cells; Bone Resorption; Cannabinoids; Cells, Cultured; Coculture Techniques; Drug Evaluation, Preclinical; Drug Inverse Agonism; Female; Indoles; Mice; Mice, Inbred C57BL; Mice, Knockout; Organ Size; Osteoclasts; Ovariectomy; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB2 | 2008 |
Involvement of cannabinoid-1 and cannabinoid-2 receptors in septic ileus.
Topics: Analysis of Variance; Animals; Cannabinoids; Dose-Response Relationship, Drug; Dronabinol; Electrophysiology; Enzyme-Linked Immunosorbent Assay; Gastrointestinal Motility; Gastrointestinal Transit; Ileus; Interleukin-6; Jejunal Diseases; Jejunum; Lipopolysaccharides; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Sepsis; Tumor Necrosis Factor-alpha | 2010 |
Anandamide reduces intracellular Ca2+ concentration through suppression of Na+/Ca2+ exchanger current in rat cardiac myocytes.
Topics: Aniline Compounds; Animals; Arachidonic Acids; Calcium; Cannabinoids; Cell Separation; Endocannabinoids; GTP-Binding Protein alpha Subunits, Gi-Go; Heart Ventricles; Indoles; Intracellular Space; Ion Channel Gating; Male; Myocardial Ischemia; Myocytes, Cardiac; Pertussis Toxin; Phenyl Ethers; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Sodium-Calcium Exchanger; Solutions | 2013 |
Increase of mesenchymal stem cell migration by cannabidiol via activation of p42/44 MAPK.
Topics: Cannabidiol; Cannabinoids; Cell Differentiation; Cell Movement; Cells, Cultured; Cyclohexanes; Flavonoids; Gene Expression Regulation, Enzymologic; Humans; Indoles; Mesenchymal Stem Cells; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Osteoblasts; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB2; Resorcinols | 2014 |
Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: mechanism of action and possible interactions with cholinergic system.
Topics: Animals; Antidepressive Agents; Cannabinoids; Depressive Disorder; Disease Models, Animal; Indoles; Ligands; Male; Mice; Motor Activity; Nicotine; Oleic Acids; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Scopolamine; Swimming | 2015 |
Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands.
Topics: Animals; Avoidance Learning; Behavior, Animal; Benzoxazines; Biomarkers; Brain; Cannabinoids; Indoles; Male; Malondialdehyde; Memory; Mice; Morpholines; Naphthalenes; Oxidative Stress; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2016 |
Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks.
Topics: Animals; Arachidonic Acids; Benzamides; Biphenyl Compounds; Blood Pressure; Cannabinoids; Carbamates; Corticosterone; Dorsomedial Hypothalamic Nucleus; Endocannabinoids; Indoles; Male; Microinjections; N-Methylaspartate; Panic Disorder; Piperidines; Pyrazoles; Rats | 2019 |
Cannabidiol inhibits sucrose self-administration by CB1 and CB2 receptor mechanisms in rodents.
Topics: Animals; Behavior, Animal; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabinoids; Feeding Behavior; Indoles; Mice; Mice, Knockout; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Self Administration; Sucrose; Sweetening Agents | 2020 |